CD4 and diabetes mellitus: Overall, our results indicate that NOD Vγ4+ γδ T cells inhibit the development of diabetes, and suggest that the process by which they do so involves IL-17 production and/or promotion of regulatory CD4+ αβ T cell (Treg) development in the pancreatic lymph nodes.